Mini-Reviews in Medicinal Chemistry

Editor-in-Chief:

Back



Editorial (Thematic Issue: The Elephant in the Room: Targeting Ras for Therapeutic Development) free to download

Volume:16   Issue:5
Pp: 343-344
Shuxing Zhang and Zhi Tan
DOI: 10.2174/138955751605160201155950

Past, Present, and Future of Targeting Ras for Cancer Therapies

Volume:16   Issue:5
Pp: 345-357
Zhi Tan and Shuxing Zhang
DOI: 10.2174/1389557515666151001154111

How to Target Activated Ras Proteins: Direct Inhibition vs. Induced Mislocalization

Volume:16   Issue:5
Pp: 358-369
Ethan J. Brock, Kyungmin Ji, John J. Reiners and Raymond R. Mattingly
DOI: 10.2174/1389557515666151001154002

RAS/Effector Interactions from Structural and Biophysical Perspective open access plus

Volume:16   Issue:5
Pp: 370-375
Ariel Erijman and Julia M. Shifman
DOI: 10.2174/1389557515666151001141838

Direct Inhibitors of Ras-Effector Protein Interactions

Volume:16   Issue:5
Pp: 376-382
Punit Upadhyaya, Walaa Bedewy and Dehua Pei
DOI: 10.2174/1389557515666151001141713

Getting a Handle on RAS-targeted Therapies: Cysteine Directed Inhibitors

Volume:16   Issue:5
Pp: 383-390
Minh V. Huynh and Sharon L. Campbell
DOI: 10.2174/1389557515666151001154352

Ras Dimer Formation as a New Signaling Mechanism and Potential Cancer Therapeutic Target open access plus

Volume:16   Issue:5
Pp: 391-403
Mo Chen, Alec Peters, Tao Huang and Xiaolin Nan
DOI: 10.2174/1389557515666151001152212